Breath Test Feasibility Trial for COVID-19 Infection Diagnosis
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Provide an adequate sample and compare the signals given from the two groups.
研究概览
简要总结
This study is designed to look at the effectiveness of a new technology call Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients. Participation in this study is expected to take less than one month and will consist of a breath sample being taken by the research team, a cheek swab being taken by the research team, a questionnaire that will be completed by the participant with the help of the research teams, and a review of your medical record.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18 years and older
- •Patients that present for COVID-19 testing, have tested Covid negative, or Covid Positive patients.
排除标准
- •Unable to consent
- •Patients on a ventilator
- •Pregnant Women
结局指标
主要结局
Provide an adequate sample and compare the signals given from the two groups.
时间窗: 10 minutes
The samples from the participants will be analyzed to identify the different signals given from Covid-19 positive patients and Covid-19 negative patients
次要结局
未报告次要终点
研究者
Gerard Silvestri, MD
Professor of Medicine
Medical University of South Carolina